1.Disseminated Histoplasmosis Presenting as Addisonian Crisis: A Diagnostic Mimic of Tuberculosis With Bilateral Adrenal Masses
Aminuddin Baki Amran ; Nur Aini Eddy Warman ; Aimi Fadilah Mohamad ; Nur Haziqah Baharum ; Mohd Hazriq Awang ; Fatimah Zaherah Mohamed Shah ; Rohana Abdul Ghani
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):22-23
Introduction:
Disseminated histoplasmosis is a rare but important cause
of adrenal insufficiency (AI), particularly in tuberculosis
(TB)-endemic regions, where it may mimic granulomatous
diseases. Adrenal involvement occurs in up to 80% of
disseminated cases, although overt AI is less common.
Reported cases described bilateral adrenal masses
mimicking malignancy or TB, even in immunocompetent
individuals. Addisonian crisis may be the initial
manifestation, especially when the diagnosis is delayed. In
TB-endemic settings, fungal infections are often overlooked,
leading to delayed diagnosis and inappropriate therapy.
Case:
We reported a case of a 68-year-old male with underlying
diabetes mellitus who presented with fever, cough,
dysphagia, and weight loss for 1 month. He was
empirically treated as smear-negative disseminated TB.
On day 2 of therapy, he developed hypotension (80/50
mmHg), hypoglycemia (3.9 mmol/L), hyponatremia
(Na 129 mmol/L), and hyperkalemia (K 5.1 mmol/L),
suggestive of adrenal crisis, and was started on intravenous
hydrocortisone. Serum cortisol prior to treatment was 61 nmol/L. Computed tomography (CT) imaging revealed
bilateral lipid-poor adrenal lesions (right: 3.6 × 2.2 × 4.9 cm,
Hounsfield Unit (HU) 36 and absolute washout 33%; left:
3.5 × 2.4 × 5.4 cm; HU 35 and absolute washout 17%),
raising suspicion of infectious or malignant etiologies.
Endoscopic ultrasound-guided biopsy demonstrated
necrotizing granulomatous inflammation with budding
fungal yeasts on Pituitary Apoplexy Score and GMS
staining, consistent with Histoplasma capsulatum. TB and
malignancy were excluded. He received amphotericin B for
14 days, followed by oral itraconazole for 1 year, and oral
hydrocortisone replacement. At 1-year follow-up, adrenal
lesions remained stable on CT images, and he continued
to require hydrocortisone replacement.
Conclusion
This case highlights the importance of considering
disseminated histoplasmosis as a differential diagnosis
of bilateral adrenal masses with AI, especially with poor
response to anti-TB therapy. Early tissue diagnosis is
essential, as imaging findings are non-specific. Prompt
recognition is critical to prevent life-threatening adrenal
crisis and improve clinical outcomes.
Histoplasmosis
;
Tuberculosis
2.Expanding the Spectrum of Vitamin D-Dependent Ricket Type 2: Dominant-Negative VDR Mutation and Postpubertal Calcium Adaptation
Mohd Hazriq Awang ; Shireene Ratna Vethakkan ; Ooi Ying Guat ; Tharsini Sarvanandan
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):70-
Introduction:
Vitamin D-dependent rickets type 2 (VDDR2) is traditionally defined by biallelic vitamin D receptor (VDR) mutations
causing resistance to 1,25(OH)₂D. We describe a case of the
classical VDDR2 phenotype with a single VDR mutation
and an interesting physiological adaptation.
Case:
A female diagnosed with rickets at age three presented with
a femoral fracture, severe short stature, hypocalcemia (2.1
mmol/L; NR 2.35–2.70), hypophosphatemia (0.8 mmol/L;
NR 1.5–2.10), and evidence of renal phosphate wasting
(TMP/GFR 0.5 mmol/L; NR 1.5–2.4). Biochemistry showed
markedly elevated alkaline phosphatase (1,227 IU/L; NR
50–136) and secondary hyperparathyroidism (20.7 pmol/L;
NR 0.8–7.8). Despite hypocalcemia, 1,25(OH)₂D was
significantly elevated (>450 pmol/L; NR 60–150), consistent
with VDDR2. There was no initial family history; however,
subsequent evaluation of her mother—prompted by the
patient’s diagnosis—revealed a similar biochemical profile,
along with short stature (142 cm) and a history of multiple
fractures. Genetic analysis in both individuals identified a heterozygous missense mutation in exon 10 of the VDR
gene, affecting the ligand-binding domain, supporting a
pattern of dominant inheritance. The patient was treated
with cholecalciferol (1,200 IU daily), calcitriol (5–6 µg
daily), and calcium carbonate (2,000 mg daily). Although
biochemical responsiveness to therapy was evident,
poor adherence resulted in suboptimal metabolic control
throughout childhood and adolescence, including a second
fracture at age 15 and a final adult height of 124 cm. Notably,
calcium and phosphate levels progressively normalized
after puberty, with sustained biochemical stability despite
the patient omitting the treatment.
Conclusion
This case provides two important insights. First, it represents the fourth reported case worldwide demonstrating
a dominant-negative effect of a VDR gene mutation,
whereby a single mutant receptor interferes with wildtype VDR function. Second, it highlights postpubertal
calcium adaptation, in which vitamin D–independent
intestinal absorption may restore mineral homeostasis, and
disease severity can attenuate over time through adaptive
physiological mechanisms.
Calcium
;
Mutation
;
Vitamin D
;
Rickets


Result Analysis
Print
Save
E-mail